Affordable Access

Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series.

Authors
  • Rodriguez-Luna, Hector
  • Khatib, Amer
  • Sharma, Pratima
  • De Petris, Giovanni
  • Williams, James W
  • Ortiz, Jose
  • Hansen, Kathleen
  • Mulligan, David
  • Moss, Adyr
  • Douglas, David D
  • Balan, Vijayan
  • Rakela, Jorge
  • Vargas, Hugo E
Type
Published Article
Journal
Transplantation Journal
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Jan 27, 2004
Volume
77
Issue
2
Pages
190–194
Identifiers
PMID: 14742979
Source
Medline
License
Unknown

Abstract

Post-OLT HCV recurrence can be safely treated with PEG-IFN and RIB. Bone marrow toxicity, depression, and rejection are limiting factors that require aggressive management. There was short-term histologic benefit to the use of this regimen, even in those patients without viral clearance.

Report this publication

Statistics

Seen <100 times